33rd Annual Symposium on NHP Models for AIDS
第 33 届 NHP 艾滋病模型年度研讨会
基本信息
- 批准号:9065384
- 负责人:
- 金额:$ 7.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAnimal ModelAnimalsAreaAwardBiotechnologyCaliforniaCollaborationsCytomegalovirusDestinationsDevelopmentDiseaseEducational workshopFamilyFeesFosteringFundingGenomicsHIVHIV InfectionsHIV therapyHIV vaccineHealthcare SystemsImmunologyIndividualIndustryInfectionInfection preventionInstitutionInternationalInvestigationJournalsKnowledgeManuscriptsMedicalModelingOralPathogenesisPatientsPharmacologic SubstancePreventionPrevention strategyPrimatesPublicationsRecording of previous eventsRecordsRequest for ApplicationsResearchResearch PersonnelReview CommitteeSan FranciscoScheduleScientistSelection CriteriaTimeTranslationsUnited States National Institutes of HealthUniversitiesViral Pathogenesisabstractingbaseclinical careclinical practicecongenital cytomegaloviruscostexperienceinnovationmeetingsmembermicrobiomenonhuman primatenovelnovel strategiesoriginalityposterspre-clinicalprogramsprotective efficacypublic health relevancesuccesssymposiumtherapeutic vaccinetransmission processvirology
项目摘要
DESCRIPTION (provided by applicant): This R13 application request funds to partially support the costs for planning, organizing, publicizing, and hosting the 33rd Annual Symposium on Nonhuman Primate Models for AIDS. The Symposium will be hosted by the California National Primate Research Center (CNPRC), University of California, Davis (UC Davis), and will be held on October 14-16, 2015, at the Portola Hotel, Monterey, California. The Annual Symposium on Nonhuman Primate Models for AIDS has become the destination for the sharing, presenting and exchanging the most recent advances in AIDS research utilizing nonhuman primate models of AIDS. An attendance of approximately 250 scientists from national and international academic institutions and private industry is expected based on the past records of the conference participation. The most recent findings in viral pathogenesis, immunology, virology, vaccines, therapeutics, and genomics will be presented. Novel approaches for HIV eradication strategies will be discussed. An emphasis of this year's symposium is to provide forums for dialog between clinicians and researchers to facilitate refinement of the animal models of HIV in ways that enhance translation of prevention, treatment, and cure findings in animals to HIV patients. The meeting will consist of a combination of platform presentations and poster sessions. The scientific sessions will be devoted to specific focus areas of research. Each session will be hosted by an invited Chair and a co-Chair. The Chair will moderate the first half of the session and will begin the session by giving a 30- minute overview presentation. The co-Chair will moderate the second half of the session and facilitate discussion at the end of each session. The Scientific Program Committee consists of 14 members representing the National Primate Centers, academic institutions, and pharmaceutical and biotechnology industry, and the committee will review abstracts and assign oral or poster presentation for each of the scientific sessions. The conference organizing committee (nine members) will participate in the planning and organization of the conference. Criteria for selection of the abstracts will be
based on the originality and quality of the content. Those individuals giving platform presentations will be asked to submit their presentations in manuscript form for publication in the Journal of Medical Primatology (Dr. Preston Marx, Tulane, will serve as Editor). In addition, there will be poster sessions for those meritorious presentations that cannot be accommodated in one of the five platform sessions. The conference will include an opening day welcome reception and introductory talk (Dr. Murray Gardner, UC Davis) followed by a keynote presentation by Dr. James Hildreth (UC Davis/Meharry University), recipient of the NIH Director's Pioneer Award. On the second day, platform presentations and a poster session reception will be held. On the third day of the symposium, a banquet will be hosted following the platform presentations and a poster session. The proposed conference will facilitate an exchange of most recent findings, new ideas and concepts and collaborative interactions to define the mechanisms of HIV disease and to develop multi-disciplinary collaborative interactions for innovative studies on HIV vaccines to prevent infection and therapies to control and eradicate HIV infection.
描述(由申请提供):此R13申请要求资金部分支持计划,组织,发布和举办第33届艾滋病非人类灵长类动物模型的年度研讨会。该研讨会将由加利福尼亚州加利福尼亚大学戴维斯分校(UC戴维斯)的加利福尼亚国家灵长类动物研究中心(CNPRC)主持,并于2015年10月14日至16日在加利福尼亚州蒙特雷的Portola Hotel举行。艾滋病非人类灵长类动物模型的年度研讨会已成为共享,通过非人类灵长类动物艾滋病模型的艾滋病研究的最新进展。根据会议参与的过去记录,预计来自国家和国际学术机构和私营企业的大约250名科学家的出席率。将提出病毒发病机理,免疫学,病毒学,疫苗,治疗和基因组学的最新发现。将讨论消除艾滋病毒策略的新方法。今年的研讨会的重点是为临床医生和研究人员之间的对话论坛提供论坛,以支持艾滋病毒动物模型的细化,以增强动物对艾滋病毒患者的预防,治疗和治愈发现的翻译。会议将包括平台演示文稿和海报会议的组合。科学会议将部署到特定的研究重点领域。每个会议将由受邀椅子和联合主席主持。主席将在会议的上半场举办会议,并通过给出30分钟的概述演示文稿开始会议。联合主席将在课程的后半部分进行调节,并在每个会议结束时促进讨论。科学计划委员会由14名代表国家灵长类动物中心,学术机构以及制药和生物技术行业的成员组成,委员会将为每个科学会议审查摘要并分配口头或海报陈述。会议组织委员会(九个成员)将参加会议的计划和组织。选择摘要的标准将是
基于内容的独创性和质量。那些提供平台演示文稿的人将被要求以手稿形式提交其在《医学原理杂志》中发表的演讲(杜兰(Tulane)的普雷斯顿·马克思(Preston Marx)博士将担任编辑)。此外,将在五个平台会议之一中为那些有功的演讲提供海报会议。会议将包括开幕日欢迎招待会和介绍演讲(加州大学戴维斯分校的默里·加德纳博士),然后由NIH导演先驱奖的获得者詹姆斯·希尔德雷斯(UC Davis/Meharry University)詹姆斯·希尔德雷斯博士(UC Davis/Meharry University)进行了主题演讲。在第二天,将举行平台演示和海报会议招待会。在研讨会的第三天,将在平台演示文稿和海报会议之后举办宴会。拟议的会议将促进最新发现,新思想和概念以及协作互动的交换,以定义HIV疾病的机制,并为HIV疫苗的创新研究开发多学科的合作互动,以防止感染和疗法控制和放射性HIV感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Satya Dandekar其他文献
Satya Dandekar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Satya Dandekar', 18)}}的其他基金
Molecules and Pathways at the Coccidioides Host-Pathogen Interface
球孢子菌宿主-病原体界面的分子和途径
- 批准号:
10364963 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Immune and metabolic correlates of Coccidioides disease spectrum and outcomes
球孢子菌疾病谱和结果的免疫和代谢相关性
- 批准号:
10540815 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Molecules and Pathways at the Coccidioides Host-Pathogen Interface
球孢子菌宿主-病原体界面的分子和途径
- 批准号:
10540795 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Immune and metabolic correlates of Coccidioides disease spectrum and outcomes
球孢子菌疾病谱和结果的免疫和代谢相关性
- 批准号:
10364969 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
"Corral and Kill" strategy for HIV eradication using MSC in an SIV model
在 SIV 模型中使用 MSC 根除 HIV 的“围堵和杀死”策略
- 批准号:
10023879 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
"Corral and Kill" strategy for HIV eradication using MSC in an SIV model
在 SIV 模型中使用 MSC 根除 HIV 的“围堵和杀死”策略
- 批准号:
10368941 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
"Corral and Kill" strategy for HIV eradication using MSC in an SIV model
在 SIV 模型中使用 MSC 根除 HIV 的“围堵和杀死”策略
- 批准号:
10579905 - 财政年份:2020
- 资助金额:
$ 7.5万 - 项目类别:
Early HIV Effects on Gut Immunity and Inflammation for Seeding Viral Reservoirs
早期艾滋病毒对肠道免疫和炎症的影响,以播种病毒库
- 批准号:
9154447 - 财政年份:2016
- 资助金额:
$ 7.5万 - 项目类别:
PATHOGENESIS OF INTESTINAL DYSFUNCTION IN SIMIAN AIDS
猿猴艾滋病肠功能障碍的发病机制
- 批准号:
8357341 - 财政年份:2011
- 资助金额:
$ 7.5万 - 项目类别:
INTESTINAL CYTOKINE AND T CELL HEMEOSTASIS IN SIV INFECTION
SIV 感染中的肠道细胞因子和 T 细胞止血作用
- 批准号:
8357367 - 财政年份:2011
- 资助金额:
$ 7.5万 - 项目类别:
相似海外基金
Pigtail Macaque Model of Human-Simian Immunodeficiency Virus Infection
人猿免疫缺陷病毒感染的尾猴模型
- 批准号:
10484431 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Role of phospholipids in antifungal drug resistance in Cryptococcus neoformans
磷脂在新型隐球菌抗真菌药物耐药性中的作用
- 批准号:
10654524 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Role of phospholipids in antifungal drug resistance in Cryptococcus neoformans
磷脂在新型隐球菌抗真菌药物耐药性中的作用
- 批准号:
10389392 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别: